Conceptio › Archive › Europe PMC
Europe PMCopen access

International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: Opportunities and Challenges

Chan A et al.
Europe PMC · Papers · License: Open Access
Open Source ↗Direct PDF ↓
diseasemultiplesclerosis
Multiple sclerosis, Disease-modifying Therapy, Cladribine Tablets, Immune Reconstitution Therapy
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 253597
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.